What is BioNtech SE (BNTX)?
BioNTech SE is a biotechnology company specializing in the development of immunotherapies based on messenger RNA (mRNA) technology. The company focuses on creating treatments and vaccines for cancer and infectious diseases by harnessing the body's immune system. BioNTech's research includes individualized cancer vaccines, antibody therapies, and cell therapies, as well as prophylactic vaccines for infectious agents. The company employs a modular mRNA platform that enables rapid development and manufacturing of therapeutic candidates. BioNTech collaborates with pharmaceutical partners and academic institutions to advance its pipeline and bring innovative therapies to market. Its work contributes to the broader field of immuno-oncology and vaccine development, emphasizing precision medicine approaches. BioNTech's technology platform integrates genomics, bioinformatics, and synthetic biology to address unmet medical needs.
BioNtech SE Stock Price Today: Live Overview
The price today is shaped by session activity, with BioNtech SE currently at $91.85. The price has moved between $87.98 and $91.44, showing a daily percentage change of 0%.
FAQ: BioNtech SE (BNTX)
What is the current price of BNTX stock?
BioNtech SE's last traded price is $91.85.
Does BNTX pay dividends?
BioNtech SE pays dividends via cash distributions (if applicable).
Does BNTX have a formal corporate presence or regional headquarters in the UAE?
BioNtech SE has a registered presence in the UAE but does not maintain an official regional office or subsidiary.
What is BNTX best known for?
BioNtech SE is most famous for its mRNA-based vaccines and immunotherapies.
What assets are typically shown together with BNTX?
Commonly shown alongside BNTX: Niagen Bioscience Inc, Alnylam, Compugen Ltd.
Latest shares articles



